Biogaia

Biogaia Enterprise Value

The Enterprise Value (EV) of Biogaia (BIOG B.ST) as of Nov 11, 2026 is 9.80 B SEK. In the previous year, Enterprise Value (EV) was 9.38 B SEK — a change of 4.50% (higher).

Enterprise Value

9.80 BSEK

YoY

4.50%

Last updated:

Enterprise Value (EV) of Biogaia is 2025 9.80 B SEK. Enterprise Value (EV) of Biogaia was 2024 9.38 B SEK. It decreases by 4.50% higher compared to the previous year.

The Biogaia Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
10.28 B SEK
Jan 1, 2019
10.41 B SEK
Jan 1, 2020
9.16 B SEK
Jan 1, 2021
9.12 B SEK
Jan 1, 2022
9.13 B SEK
Jan 1, 2023
9.06 B SEK
Jan 1, 2024
9.38 B SEK
Jan 1, 2025
9.80 B SEK
The Biogaia Enterprise Value history
YEAREnterprise ValueYoY
9.80 BSEK+4.50%
9.38 BSEK+3.51%
9.06 BSEK-0.69%
9.13 BSEK+0.02%
9.12 BSEK-0.39%
9.16 BSEK-11.97%
10.41 BSEK+1.19%
10.28 BSEK+0.32%
10.25 BSEK-0.80%
10.33 BSEK-0.37%
10.37 BSEK-0.16%
10.39 BSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Enterprise Value (EV) of Biogaia is 9.80 B SEK in 2025.

Enterprise Value (EV) of Biogaia changed from 9.38 B SEK to 9.80 B SEK, representing a 4.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Biogaia since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s SEK, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' SEK varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Biogaia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biogaia

All Key Metrics — Biogaia